Denali Therapeutics, Inc. (DNLI)
23.19
-0.57
(-2.40%)
USD |
NASDAQ |
Sep 01, 14:54
Denali Therapeutics Total Long Term Debt (Quarterly) : 27.60M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.60M |
| March 31, 2026 | 30.28M |
| December 31, 2025 | 32.82M |
| September 30, 2025 | 35.24M |
| June 30, 2025 | 37.69M |
| March 31, 2025 | 40.05M |
| December 31, 2024 | 46.01M |
| September 30, 2024 | 44.48M |
| June 30, 2024 | 40.98M |
| March 31, 2024 | 43.03M |
| December 31, 2023 | 44.98M |
| September 30, 2023 | 46.89M |
| June 30, 2023 | 48.75M |
| March 31, 2023 | 50.55M |
| December 31, 2022 | 53.03M |
| September 30, 2022 | 54.98M |
| June 30, 2022 | 55.52M |
| March 31, 2022 | 57.09M |
| December 31, 2021 | 58.55M |
| September 30, 2021 | 59.99M |
| Date | Value |
|---|---|
| June 30, 2021 | 61.40M |
| March 31, 2021 | 62.92M |
| December 31, 2020 | 64.18M |
| September 30, 2020 | 65.41M |
| June 30, 2020 | 66.61M |
| March 31, 2020 | 67.79M |
| December 31, 2019 | 68.86M |
| September 30, 2019 | 69.92M |
| June 30, 2019 | 70.91M |
| March 31, 2019 | 71.41M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |
| Sangamo Therapeutics, Inc. | 19.33M |
| Sarepta Therapeutics, Inc. | 1.046B |
| Anixa Biosciences, Inc. | 0.14M |